Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

ClinicalTrials.gov ID: NCT00105300

Public ClinicalTrials.gov record NCT00105300. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 6:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Moderate to Severe Crohn's Disease Who Have Lost Response or Are Intolerant to Infliximab

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this study is to test whether adalimumab can induce clinical remission in subjects with active Crohn's disease who have been initially treated with infliximab and either lost response or discontinued its use as a result of intolerance to the drug.

Study identification

NCT ID
NCT00105300
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2004 (Type not available)
Primary completion
Not listed
Completion
Not listed
Last update posted
Aug 15, 2006

Started 2004

United States locations

U.S. sites
46
U.S. states
26
U.S. cities
44
Facility City State ZIP Site status
Clinical Research Associates Huntsville Alabama 35801 —
Capitol Gastroenterology Consultants Medical Group, Inc. Roseville California 95661 —
Medical Associates Research Group San Diego California 92123 —
Sharp Rees-Stealy Medical Group San Diego California 92123 —
SMC-Trauma Research Englewood Colorado 80113 —
Clinical Research of West Florida, Inc Clearwater Florida 33765 —
V.A. Medical Center Gainesville Florida 32608 —
Borland-Groover Clinic Jacksonville Florida 32256 —
Shafran Gastroenterology Center Winter Park Florida 32789 —
Pinnacle Trials, Inc. Atlanta Georgia 30329 —
Atlanta Gastroenterology Assoc. Atlanta Georgia 30342 —
The University of Chicago Chicago Illinois 60673 —
Ntouch Research Peoria Illinois 60602 —
Outpatient Clinical Research Facility University of Indianapolis Indianapolis Indiana 462025250 —
University of Kentucky Medical Center Division of Digestive Diseases Lexington Kentucky 40536 —
Drug Research Services, Inc. Metairie Louisiana 70001 —
Chevy Chase Clinical Research Chevy Chase Maryland 20815 —
Charm City Research Towson Maryland 21204 —
Minnesota Gastroenterology P.A. Plymouth Minnesota 55446 —
Mayo Clinic Research Rochester Minnesota 559050002 —
Gastrointestinal Associated, P.A. Jackson Mississippi 39202 —
Glen Gordon, MD Mexico Missouri 65265 —
St. Louis Center for Clinical Research St Louis Missouri 63128 —
Atlantic Gastroenterology Associates, LLC Egg Harbor New Jersey 08234 —
Long Island Clinical Research Assoc. LLP Great Neck New York 11021 —
NY Center for Clinical Research Lake Success New York 11042 —
Mount Sinai School of Medicine IBD Research Center New York New York 10029 —
Asheville Gastroenterology Associates Ashville North Carolina 28801 —
Wake Research Associates Raleigh North Carolina 27612 —
Consultants for Clinical Research Cincinnati Ohio 45219 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Gastrointestinal and Liver Disease Consultants Dayton Ohio 45440 —
Gastroenterology Associates of Cleveland Mayfield Heights Ohio 44124 —
The Oregon Clinic, PC Gastroenterology Division Portland Oregon 97220 —
Regional Gastroenterologist Associates of Lancaster Lancaster Pennsylvania 17604 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15261 —
Columbia Gastro Associates Columbia South Carolina 29204 —
Gastrointestinal Associates Knoxville Tennessee 37909 —
Gastroenterology Center of the Mid South Memphis Tennessee 38120 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Austin Gastroenterology Austin Texas 78745 —
Wasatch Clinical Research Salt Lake City Utah 84107 —
Internal Medicine Associates Danville Virginia 25451 —
Digestive and Liver Disease Norfolk Virginia 23205 —
Spokane Digestive Disease Center Spokane Washington 99204 —
Discovery Research International, LLC Milwaukee Wisconsin 53207 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00105300, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 15, 2006 · Synced Nov 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00105300 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →